Nightingale HealthFRA:7XE -3.28%71 Market Cap is €54.33 Mil as of Jul. 04, 2026. GuruFocus rates FRA:7XE with a GF Score™ of 71/100 and a GF Value™ of €2.87 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Nightingale Health ranks worse than 56.83% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nightingale Health's share price for the quarter that ended in Dec. 2025 was €1.896. Nightingale Health's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 60.36 Mil. Therefore, Nightingale Health's market cap for the quarter that ended in Dec. 2025 was €114.44 Mil.
Nightingale Health's quarterly market cap
declined
from Dec. 2024 (€166.57 Mil) to Jun. 2025 (€154.22 Mil) and
declined
from Jun. 2025 (€154.22 Mil) to Dec. 2025 (€114.44 Mil).
Nightingale Health's annual market cap
increased
from Jun. 2023 (€50.99 Mil) to Jun. 2024 (€120.68 Mil) and
increased
from Jun. 2024 (€120.68 Mil) to Jun. 2025 (€154.22 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nightingale Health's Enterprise Value for Today is €16.40 Mil.
Nightingale Health (FRA:7XE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nightingale Health Market Cap Related Terms
Nightingale Health Market Cap Historical Data
* Premium members only.
The historical data trend for Nightingale Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Nightingale Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nightingale Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nightingale Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Nightingale Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nightingale Health's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nightingale Health (FRA:7XE) has a Market Cap of €54.33 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nightingale Health and its competitors. According to the industry distribution chart, Nightingale Health ranks #395 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 56.8%.
Is Nightingale Health's Market Cap too high?
Nightingale Health's current Market Cap is €54.33 Mil. Based on the distribution chart, Nightingale Health ranks #395 out of 695 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nightingale Health has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nightingale Health ranks #395 out of 695 companies for Market Cap. This places Nightingale Health in the lower half of its industry. The industry median Market Cap is 97.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 97.60, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nightingale Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 97.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nightingale Health's current Market Cap is €54.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Based on GuruFocus' analysis, Nightingale Health (FRA:7XE) is currently considered Possible Value Trap. The stock's GF Value™ is €2.87, compared to a current price of €0.77 — trading 73.3% below its estimated fair value. The current Market Cap is €54.33 Mil. Nightingale Health's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nightingale Health (FRA:7XE), the current Market Cap is €54.33 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nightingale Health (FRA:7XE) Overvalued in 2026?
Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued.
The current stock price of €0.77 is trading 73.3% below its estimated GF Value™ of €2.87.
GuruFocus considers Nightingale Health to be Possible Value Trap.
Key valuation signals for FRA:7XE:
Market Cap: €54.33 Mil
GF Value™: €2.87 vs. price of €0.77 (73.3% below fair value)
No single metric tells the full story. See the FRA:7XE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
71GF Score
Get the complete analysis for FRA:7XE
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7XE has been successfully added to your 
